Subjects with lower striatal DAT binding within 2 years of the clinical diagnosis of PD were more likely to develop motor-related disability, as well as cognitive impairment, psychosis, and depression after more than 5 years of follow-up [43]. The gene discussed is SLC6A3; the disease is depressive disorder.